1-2 of 2
Shebli Atrash
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma

Clinical Trials & Observations
Manisha Bhutani, Myra Robinson, David Foureau, Shebli Atrash, Barry A Paul, Fei Guo, Jason Grayson, Anna Ivanina-Foureau, Mauricio Pineda-Roman, Cindy Varga, Reed Friend, Christopher J Ferreri, Xhevahire Begic, Sarah Norek, Tiffany Drennan, Michelle B Anderson, James T Symanowski, Peter M Voorhees, Saad Z Usmani
Journal: Blood Advances
Blood Adv bloodadvances.2024014417.
https://doi.org/10.1182/bloodadvances.2024014417
Published: 2024
Includes: Supplemental data
Journal Articles

Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy

Clinical Trials & Observations
Lauren C. Peres, Laura B. Oswald, Christen M. Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J. Blue, Ciara L. Freeman, Frederick L. Locke, Melissa Alsina, Omar Castaneda Puglianini, Leyla Shune, Douglas W. Sborov, Charlotte Wagner, Danai Dima, Hamza Hashmi, James A. Davis, Mehmet H. Kocoglu, Ashraf Z. Badros, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher Ferreri, Larry D. Anderson, Jr, Aimaz Afrough, Gurbakhash Kaur, Yi Lin, Lawrence Liu, Omar Nadeem, Peter Voorhees, Jack Khouri, Joseph McGuirk, Surbhi Sidana, Doris K. Hansen, Krina Patel
Journal: Blood Advances
Blood Adv (2024) 8 (1): 251–259.
https://doi.org/10.1182/bloodadvances.2023010894
Published: 2024
Includes: Supplemental data